-
1
-
-
0028929803
-
Angiogenesis in cancer, vascular, rheumatoid and other disease
-
Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
-
(1995)
Nat Med
, vol.1
, pp. 27-31
-
-
Folkman, J.1
-
2
-
-
0030448814
-
Blood vessel formation: What is its molecular basis?
-
DOI 10.1016/S0092-8674(00)81810-3
-
Folkman J and D'Amore PA: Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155, 1996. (Pubitemid 27010098)
-
(1996)
Cell
, vol.87
, Issue.7
, pp. 1153-1155
-
-
Folkman, J.1
D'Amore, P.A.2
-
3
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
4
-
-
84975525035
-
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
-
Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
-
(1995)
N Engl J Med
, vol.333
, pp. 1757-1763
-
-
Folkman, J.1
-
5
-
-
0026446102
-
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
-
Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
-
(1992)
Nature
, vol.359
, pp. 845-848
-
-
Plate, K.H.1
Breier, G.2
Weich, H.A.3
Risau, W.4
-
6
-
-
0031106404
-
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
-
Pepper MS: Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21-43, 1997.
-
(1997)
Cytokine Growth Factor Rev
, vol.8
, pp. 21-43
-
-
Pepper, M.S.1
-
7
-
-
0042737444
-
The role of nitric oxide in cancer
-
Xu W, Liu LZ, Loizidou M, Ahmed M and Charles IG: The role of nitric oxide in cancer. Cell Res 12: 311-320, 2002. (Pubitemid 135708343)
-
(2002)
Cell Research
, vol.12
, Issue.5-6
, pp. 311-320
-
-
Xu, W.1
Liu, L.Z.2
Loizidou, M.3
Ahmed, M.4
Charles, I.G.5
-
8
-
-
0037372178
-
Inducible nitric oxide synthase expression in human colorectal cancer: Correlation with tumor angiogenesis
-
Cianchi F, Cortesini C, Fantappie O, et al: Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 162: 793-801, 2003. (Pubitemid 36237488)
-
(2003)
American Journal of Pathology
, vol.162
, Issue.3
, pp. 793-801
-
-
Cianchi, F.1
Cortesini, C.2
Fantappie, O.3
Messerini, L.4
Schiavone, N.5
Vannacci, A.6
Nistri, S.7
Sardi, I.8
Baroni, G.9
Marzocca, C.10
Perna, F.11
Mazzanti, R.12
Bechi, P.13
Masini, E.14
-
9
-
-
0025999033
-
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
-
Tischer E, Mitchell R, Hartman T, et al: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
-
(1991)
J Biol Chem
, vol.266
, pp. 11947-11954
-
-
Tischer, E.1
Mitchell, R.2
Hartman, T.3
-
11
-
-
0034655595
-
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
-
Padro T, Ruiz S, Bieker R, et al: Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95: 2637-2644, 2000. (Pubitemid 30210544)
-
(2000)
Blood
, vol.95
, Issue.8
, pp. 2637-2644
-
-
Padro, T.1
Ruiz, S.2
Bieker, R.3
Burger, H.4
Steins, M.5
Kienast, J.6
Buchner, T.7
Berdel, W.E.8
Mesters, R.M.9
-
12
-
-
0033485961
-
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
-
Aguayo A, Estey E, Kantarjian H, et al: Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94: 3717-3721, 1999.
-
(1999)
Blood
, vol.94
, pp. 3717-3721
-
-
Aguayo, A.1
Estey, E.2
Kantarjian, H.3
-
13
-
-
0034665786
-
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
-
Aguayo A, Kantarjian H, Manshouri T, et al: Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96: 2240-2245, 2000.
-
(2000)
Blood
, vol.96
, pp. 2240-2245
-
-
Aguayo, A.1
Kantarjian, H.2
Manshouri, T.3
-
14
-
-
0033806603
-
The thin red line: Angiogenesis in normal and malignant hematopoiesis
-
Bertolini F, Mancuso P, Gobbi A and Pruneri G: The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol 28: 993-1000, 2000.
-
(2000)
Exp Hematol
, vol.28
, pp. 993-1000
-
-
Bertolini, F.1
Mancuso, P.2
Gobbi, A.3
Pruneri, G.4
-
15
-
-
0031784561
-
Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
-
DOI 10.1002/(SICI)1097-4652(199812)177:3<439::A
-
Pepper MS, Mandriota SJ, Jeltsch M, Kumar V and Alitalo K: Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol 177: 439-452, 1998. (Pubitemid 28524667)
-
(1998)
Journal of Cellular Physiology
, vol.177
, Issue.3
, pp. 439-452
-
-
Pepper, M.S.1
Mandriota, S.J.2
Jeltsch, M.3
Kumar, V.4
Alitalo, K.5
-
16
-
-
0037085765
-
Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy
-
DOI 10.1182/blood.V99.6.2179
-
Dias S, Choy M, Alitalo K and Rafii S: Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99: 2179-2184, 2002. (Pubitemid 34525504)
-
(2002)
Blood
, vol.99
, Issue.6
, pp. 2179-2184
-
-
Dias, S.1
Choy, M.2
Alitalo, K.3
Rafii, S.4
-
17
-
-
0028115003
-
Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
-
Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994. (Pubitemid 24325027)
-
(1994)
Japanese Journal of Cancer Research
, vol.85
, Issue.10
, pp. 1045-1049
-
-
Toi, M.1
Hoshina, S.2
Takayanagi, T.3
Tominaga, T.4
-
18
-
-
84970070220
-
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
-
Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 3964-3968
-
-
Takahashi, Y.1
Kitadai, Y.2
Bucana, C.D.3
Cleary, K.R.4
Ellis, L.M.5
-
19
-
-
0035865450
-
Clinical implications of circulating angiogenic factors in cancer patients
-
Poon RT, Fan ST and Wong J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19: 1207-1225, 2001. (Pubitemid 32176299)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.4
, pp. 1207-1225
-
-
Poon, R.T.-P.1
Fan, S.-T.2
Wong, J.3
-
20
-
-
0030797765
-
A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
-
Salven P, Teerenhovi L and Joensuu H: A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90: 3167-3172, 1997. (Pubitemid 27444212)
-
(1997)
Blood
, vol.90
, Issue.8
, pp. 3167-3172
-
-
Salven, P.1
Teerenhovi, L.2
Joensuu, H.3
-
21
-
-
0034548821
-
Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: A single-institution study of 200 patients
-
Salven P, Orpana A, Teerenhovi L and Joensuu H: Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 96: 3712-3718, 2000.
-
(2000)
Blood
, vol.96
, pp. 3712-3718
-
-
Salven, P.1
Orpana, A.2
Teerenhovi, L.3
Joensuu, H.4
-
22
-
-
0032705222
-
Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
-
Molica S, Vitelli G, Levato D, Gandolfo GM and Liso V: Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 107: 605-610, 1999.
-
(1999)
Br J Haematol
, vol.107
, pp. 605-610
-
-
Molica, S.1
Vitelli, G.2
Levato, D.3
Gandolfo, G.M.4
Liso, V.5
-
23
-
-
0031059348
-
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
-
Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E and Folkman J: Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815-821, 1997. (Pubitemid 27106153)
-
(1997)
American Journal of Pathology
, vol.150
, Issue.3
, pp. 815-821
-
-
Perez-Atayde, A.R.1
Sallan, S.E.2
Tedrow, U.3
Connors, S.4
Allred, E.5
Folkman, J.6
-
24
-
-
0034090097
-
Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
-
Griffioen AW and Molema G: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237-268, 2000. (Pubitemid 30368433)
-
(2000)
Pharmacological Reviews
, vol.52
, Issue.2
, pp. 237-268
-
-
Griffioen, A.W.1
Molema, G.2
-
25
-
-
0141993064
-
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia
-
DOI 10.1182/blood-2002-10-2998
-
Fiedler W, Mesters R, Tinnefeld H, et al: A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. Blood 102: 2763-2767, 2003. (Pubitemid 37248845)
-
(2003)
Blood
, vol.102
, Issue.8
, pp. 2763-2767
-
-
Fiedler, W.1
Mesters, R.2
Tinnefeld, H.3
Loges, S.4
Staib, P.5
Duhrsen, U.6
Flasshove, M.7
Ottmann, O.G.8
Jung, W.9
Cavalli, F.10
Kuse, R.11
Thomalla, J.12
Serve, H.13
O'Farrell, A.M.14
Jacobs, M.15
Brega, N.M.16
Scigalla, P.17
Hossfeld, D.K.18
Berdel, W.E.19
-
26
-
-
0042343801
-
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
-
DOI 10.1056/NEJMoa021491
-
Yang JC, Haworth L, Sherry RM, et al: A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349: 427-434, 2003. (Pubitemid 36910021)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.5
, pp. 427-434
-
-
Yang, J.C.1
Haworth, L.2
Sherry, R.M.3
Hwu, P.4
Schwartzentruber, D.J.5
Topalian, S.L.6
Steinberg, S.M.7
Chen, H.X.8
Rosenberg, S.A.9
-
27
-
-
33644833910
-
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
-
DOI 10.1200/JCO.2005.02.2574
-
Motzer RJ, Michaelson MD, Redman BG, et al: Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24: 16-24, 2006. (Pubitemid 46630489)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.1
, pp. 16-24
-
-
Motzer, R.J.1
Michaelson, M.D.2
Redman, B.G.3
Hudes, G.R.4
Wilding, G.5
Figlin, R.A.6
Ginsberg, M.S.7
Kim, S.T.8
Baum, C.M.9
DePrimo, S.E.10
Li, J.Z.11
Bello, C.L.12
Theuer, C.P.13
George, D.J.14
Rini, B.I.15
-
28
-
-
33644847440
-
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
-
DOI 10.1200/JCO.2005.02.2194
-
Faivre S, Delbaldo C, Vera K, et al: Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 24: 25-35, 2006. (Pubitemid 46630490)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.1
, pp. 25-35
-
-
Faivre, S.1
Delbaldo, C.2
Vera, K.3
Robert, C.4
Lozahic, S.5
Lassau, N.6
Bello, C.7
Deprimo, S.8
Brega, N.9
Massimini, G.10
Armand, J.-P.11
Scigalla, P.12
Raymond, E.13
-
29
-
-
29044435272
-
Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies
-
Ribatti D and Vacca A: Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies. Curr Cancer Drug Targets 5: 573-578, 2005. (Pubitemid 41789597)
-
(2005)
Current Cancer Drug Targets
, vol.5
, Issue.8
, pp. 573-578
-
-
Ribatti, D.1
Vacca, A.2
-
30
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342, 2004. (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
31
-
-
1642321097
-
Evaluating Antiangiogenesis Agents in the Clinic: The Eastern Cooperative Oncology Group Portfolio of Clinical Trials
-
DOI 10.1158/1078-0432.CCR-03-0238
-
Sparano JA, Gray R, Giantonio B, O'Dwyer P and Comis RL: Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Clin Cancer Res 10: 1206-1211, 2004. (Pubitemid 38365208)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.4
, pp. 1206-1211
-
-
Sparano, J.A.1
Gray, R.2
Giantonio, B.3
O'Dwyer, P.4
Comis, R.L.5
-
32
-
-
0034523201
-
Co-operative study group for childhood acute lymphoblastic leukemia (COALL): Long-term follow-up of trials 82, 85, 89 and 92
-
DOI 10.1038/sj.leu.2401974
-
Harms DO and Janka-Schaub GE: Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14: 2234-2239, 2000. (Pubitemid 32042264)
-
(2000)
Leukemia
, vol.14
, Issue.12
, pp. 2234-2239
-
-
Harms, D.O.1
Janka-Schaub, G.E.2
-
33
-
-
0023277545
-
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
-
DOI 10.1006/abio.1987.9999
-
Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
-
(1987)
Analytical Biochemistry
, vol.162
, Issue.1
, pp. 156-159
-
-
Chomczynski, P.1
Sacchi, N.2
-
34
-
-
0033957420
-
Evidence of increased angiogenesis in patients with acute myeloid leukemia
-
Hussong JW, Rodgers GM and Shami PJ: Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95: 309-313, 2000. (Pubitemid 30017257)
-
(2000)
Blood
, vol.95
, Issue.1
, pp. 309-313
-
-
Hussong, J.W.1
Rodgers, G.M.2
Shami, P.J.3
-
35
-
-
0030933923
-
Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
-
Fiedler W, Graeven U, Ergun S, et al: Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89: 1870-1875, 1997. (Pubitemid 27132100)
-
(1997)
Blood
, vol.89
, Issue.6
, pp. 1870-1875
-
-
Fiedler, W.1
Graeven, U.2
Ergun, S.3
Verago, S.4
Kilic, N.5
Stockschlader, M.6
Hossfeld, D.K.7
-
36
-
-
0034604110
-
Role of transforming growth factor beta in human disease
-
DOI 10.1056/NEJM200005043421807
-
Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.18
, pp. 1350-1358
-
-
Blobe, G.C.1
Schiemann, W.P.2
Lodish, H.F.3
-
37
-
-
0035689762
-
Malignant cells, directors of the malignant process: Role of transforming growth factor-beta
-
Teicher BA: Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 20: 133-143, 2001.
-
(2001)
Cancer Metastasis Rev
, vol.20
, pp. 133-143
-
-
Teicher, B.A.1
-
38
-
-
0035153463
-
Role of transforming growth factor beta in cancer
-
Pasche B: Role of transforming growth factor beta in cancer. J Cell Physiol 186: 153-168, 2001.
-
(2001)
J Cell Physiol
, vol.186
, pp. 153-168
-
-
Pasche, B.1
-
39
-
-
0035175418
-
Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia
-
DOI 10.1159/000046596
-
Brandao MM, Soares E, Salles TS and Saad ST: Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia. Acta Haematol 106: 95-99, 2001. (Pubitemid 33079263)
-
(2001)
Acta Haematologica
, vol.106
, Issue.3
, pp. 95-99
-
-
Brandao, M.M.1
Soares, E.2
Salles, T.S.I.3
Saad, S.T.O.4
-
40
-
-
0032147236
-
B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
-
Zhao H, Dugas N, Mathiot C, et al: B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92: 1031-1043, 1998. (Pubitemid 28355488)
-
(1998)
Blood
, vol.92
, Issue.3
, pp. 1031-1043
-
-
Zhao, H.1
Dugas, N.2
Mathiot, C.3
Delmer, A.4
Dugas, B.5
Sigaux, F.6
Kolb, J.-P.7
-
41
-
-
0033898269
-
Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity
-
Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J and Palmblad J: Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 157: 15-19, 2000. (Pubitemid 30641719)
-
(2000)
American Journal of Pathology
, vol.157
, Issue.1
, pp. 15-19
-
-
Lundberg, L.G.1
Lerner, R.2
Sundelin, P.3
Rogers, R.4
Folkman, J.5
Palmblad, J.6
-
42
-
-
0028967690
-
Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells
-
Allouche M, Bayard F, Clamens S, Fillola G, Sie P and Amalric F: Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 9: 77-86, 1995.
-
(1995)
Leukemia
, vol.9
, pp. 77-86
-
-
Allouche, M.1
Bayard, F.2
Clamens, S.3
Fillola, G.4
Sie, P.5
Amalric, F.6
-
43
-
-
0033083962
-
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
-
Bellamy WT, Richter L, Frutiger Y and Grogan TM: Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59: 728-733, 1999. (Pubitemid 29076074)
-
(1999)
Cancer Research
, vol.59
, Issue.3
, pp. 728-733
-
-
Bellamy, W.T.1
Richter, L.2
Frutiger, Y.3
Grogan, T.M.4
-
44
-
-
0025291743
-
In situ detection of basic fibroblast growth factor by highly specific antibodies
-
Schulze-Osthoff K, Risau W, Vollmer E and Sorg C: In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137: 85-92, 1990. (Pubitemid 20229591)
-
(1990)
American Journal of Pathology
, vol.137
, Issue.1
, pp. 85-92
-
-
Schulze-Osthoff, K.1
Risau, W.2
Vollmer, E.3
Sorg, C.4
-
45
-
-
0030923575
-
Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia
-
Fielder W, Graeven U, Ergun S, et al: Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 11: 1234-1237, 1997. (Pubitemid 27387298)
-
(1997)
Leukemia
, vol.11
, Issue.8
, pp. 1234-1237
-
-
Fielder, W.1
Graeven, U.2
Ergun, S.3
Verago, S.4
Kilic, N.5
Stockschlader, M.6
Hossfeld, D.K.7
-
46
-
-
18844471324
-
Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
-
Salven P, Lymboussaki A, Heikkila P, et al: Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153: 103-108, 1998. (Pubitemid 28317512)
-
(1998)
American Journal of Pathology
, vol.153
, Issue.1
, pp. 103-108
-
-
Salven, P.1
Lymboussaki, A.2
Heikkila, P.3
Jaaskela-Saari, H.4
Enholm, B.5
Aase, K.6
Von Euler, G.7
Eriksson, U.8
Alitalo, K.9
Joensuu, H.10
-
47
-
-
0029842830
-
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
-
DOI 10.1038/nm1096-1096
-
Gabrilovich DI, Chen HL, Girgis KR, et al: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096-1103, 1996. (Pubitemid 26338628)
-
(1996)
Nature Medicine
, vol.2
, Issue.10
, pp. 1096-1103
-
-
Gabrilovich, D.I.1
Chen, H.L.2
Girgis, K.R.3
Cunningham, H.T.4
Meny, G.M.5
Nadaf, S.6
Kavanaugh, D.7
Carbone, D.P.8
-
48
-
-
0032400862
-
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
-
Gabrilovich D, Ishida T, Oyama T, et al: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92: 4150-4166, 1998. (Pubitemid 28544331)
-
(1998)
Blood
, vol.92
, Issue.11
, pp. 4150-4166
-
-
Gabrilovich, D.1
Ishida, T.2
Oyama, T.3
Ran, S.4
Kravtsov, V.5
Nadaf, S.6
Carbone, D.P.7
-
49
-
-
0034655957
-
Vascular endothelial growth factor and interleukin-6 in paracrine tumor- stromal cell interactions in multiple myeloma
-
Dankbar B, Padro T, Leo R, et al: Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95: 2630-2636, 2000. (Pubitemid 30210543)
-
(2000)
Blood
, vol.95
, Issue.8
, pp. 2630-2636
-
-
Dankbar, B.1
Padro, T.2
Leo, R.3
Feldmann, B.4
Kropff, M.5
Mesters, R.M.6
Serve, H.7
Berdel, W.E.8
Kienast, J.9
-
50
-
-
0026034432
-
Role of nitric oxide synthesis in macrophage antimicrobial activity
-
Nathan CF and Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70, 1991.
-
(1991)
Curr Opin Immunol
, vol.3
, pp. 65-70
-
-
Nathan, C.F.1
Hibbs Jr., J.B.2
-
51
-
-
0034769118
-
Nitric oxide and the immune response
-
Bogdan C: Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
-
(2001)
Nat Immunol
, vol.2
, pp. 907-916
-
-
Bogdan, C.1
-
52
-
-
0033968432
-
The role of nitric oxide in innate immunity
-
DOI 10.1034/j.1600-065X.2000.917307.x
-
Bogdan C, Rollinghoff M and Diefenbach A: The role of nitric oxide in innate immunity. Immunol Rev 173: 17-26, 2000. (Pubitemid 30095207)
-
(2000)
Immunological Reviews
, vol.173
, pp. 17-26
-
-
Bogdan, C.1
Rollinghoff, M.2
Diefenbach, A.3
-
53
-
-
0025860655
-
Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells
-
Li LM, Kilbourn RG, Adams J and Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 2531-2535, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 2531-2535
-
-
Li, L.M.1
Kilbourn, R.G.2
Adams, J.3
Fidler, I.J.4
-
54
-
-
0007733268
-
Induction of nitric oxide production by natural killer cells: Its role in tumor cell death
-
DOI 10.1006/niox.1999.0243
-
Jyothi MD and Khar A: Induction of nitric oxide production by natural killer cells: its role in tumor cell death. Nitric Oxide 3: 409-418, 1999. (Pubitemid 29531868)
-
(1999)
Nitric Oxide - Biology and Chemistry
, vol.3
, Issue.5
, pp. 409-418
-
-
Jyothi, M.D.1
Khar, A.2
-
55
-
-
0027958098
-
Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells
-
Dong Z, Staroselsky AH, Qi X, Xie K and Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793, 1994. (Pubitemid 24068338)
-
(1994)
Cancer Research
, vol.54
, Issue.3
, pp. 789-793
-
-
Dong, Z.1
Staroselsky, A.H.2
Qi, X.3
Xie, K.4
Fidler, I.J.5
-
56
-
-
0028929559
-
Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells
-
Xie K, Huang S, Dong Z, et al: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995.
-
(1995)
J Exp Med
, vol.181
, pp. 1333-1343
-
-
Xie, K.1
Huang, S.2
Dong, Z.3
-
57
-
-
0032503018
-
Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene
-
Juang SH, Xie K, Xu L, et al: Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther 9: 845-854, 1998. (Pubitemid 28197371)
-
(1998)
Human Gene Therapy
, vol.9
, Issue.6
, pp. 845-854
-
-
Juang, S.-H.1
Xie, K.2
Xu, L.3
Shi, Q.4
Wang, Y.5
Yoneda, J.6
Fidler, I.J.7
-
58
-
-
0036274364
-
NO-mediated chemoresistance in C6 glioma cells
-
Yang DI, Yin JH, Mishra S, Mishra R and Hsu CY: NO-mediated chemoresistance in C6 glioma cells. Ann NY Acad Sci 962: 8-17, 2002. (Pubitemid 34592296)
-
(2002)
Annals of the New York Academy of Sciences
, vol.962
, pp. 8-17
-
-
Yang, D.-I.1
Yin, J.-H.2
Mishra, S.3
Mishra, R.A.J.4
Hsu, C.Y.5
-
60
-
-
0028917191
-
Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
-
Genaro AM, Hortelano S, Alvarez A, Martinez C and Bosca L: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95: 1884-1890, 1995.
-
(1995)
J Clin Invest
, vol.95
, pp. 1884-1890
-
-
Genaro, A.M.1
Hortelano, S.2
Alvarez, A.3
Martinez, C.4
Bosca, L.5
-
61
-
-
0031416664
-
Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide
-
DOI 10.1006/niox.1997.0133
-
Dimmeler S and Zeiher AM: Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1: 275-281, 1997. (Pubitemid 28078114)
-
(1997)
Nitric Oxide - Biology and Chemistry
, vol.1
, Issue.4
, pp. 275-281
-
-
Dimmeler, S.1
Zeiher, A.M.2
|